Aktis Oncology, Inc. Common stock (AKTS) — Tangible Net Worth Ratio
Aktis Oncology, Inc. Common stock (AKTS) has a Tangible Net Worth Ratio of 68.5% as of March 2024. This metric is calculated by deducting intangible assets ($13.22 Million) from net assets ($41.91 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Aktis Oncology, Inc. Common stock (AKTS) net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Aktis Oncology, Inc. Common stock Tangible Net Worth Ratio (2013–2023)
This chart shows how Aktis Oncology, Inc. Common stock's Tangible Net Worth Ratio has changed across 19 annual periods from 2013 to 2023. As of March 2024, the ratio stands at 68.5%, reflecting net assets of $41.91 Million with intangible assets of $13.22 Million USD. Also explore net asset growth rate of Aktis Oncology, Inc. Common stock to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Aktis Oncology, Inc. Common stock (2013–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for Aktis Oncology, Inc. Common stock from 2013 to 2023, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Aktis Oncology, Inc. Common stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 82.3% | $86.24 Million | $15.24 Million | $148.92 Million | ▼ -9.0 pp |
| 2022 | 91.3% | $103.43 Million | $8.99 Million | $161.34 Million | ▲ +0.0 pp |
| 2021 | 91.3% | $103.43 Million | $8.99 Million | $161.34 Million | ▼ -8.2 pp |
| 2021 | 99.5% | $117.41 Million | $572.00K | $124.99 Million | ▲ +0.8 pp |
| 2020 | 98.7% | $41.49 Million | $544.00K | $71.43 Million | ▲ +0.0 pp |
| 2020 | 98.7% | $41.49 Million | $544.00K | $71.43 Million | ▲ +0.2 pp |
| 2019 | 98.5% | $25.95 Million | $388.00K | $47.95 Million | ▲ +0.0 pp |
| 2019 | 98.5% | $25.95 Million | $388.00K | $47.95 Million | ▲ +0.4 pp |
| 2018 | 98.1% | $13.85 Million | $264.30K | $29.31 Million | ▲ +0.0 pp |
| 2018 | 98.1% | $13.85 Million | $264.30K | $29.31 Million | ▼ -0.5 pp |
| 2017 | 98.6% | $15.01 Million | $206.53K | $18.09 Million | ▲ +0.0 pp |
| 2017 | 98.6% | $15.01 Million | $206.53K | $18.09 Million | ▲ +1.3 pp |
| 2016 | 97.3% | $2.68 Million | $71.23K | $4.54 Million | ▲ +0.0 pp |
| 2015 | 97.3% | $2.68 Million | $71.23K | $4.54 Million | ▼ -1.9 pp |
| 2015 | 99.3% | $4.19 Million | $31.08K | $4.51 Million | ▲ +0.0 pp |
| 2014 | 99.3% | $4.19 Million | $31.08K | $4.51 Million | ▼ -0.7 pp |
| 2014 | 100.0% | $9.21K | $0.00 | $9.52K | ▲ +0.0 pp |
| 2013 | 100.0% | $8.79K | $0.00 | $9.10K | ▲ +0.0 pp |
| 2013 | 100.0% | $8.79K | $0.00 | $9.10K | — |